Literature DB >> 22529731

Acellular versus whole-cell pertussis vaccines.

S Halperin1, D Scheifele, N Macdonald.   

Abstract

Year:  1992        PMID： 22529731      PMCID： PMC3328021          DOI： 10.1155/1992/564683

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  5 in total

1.  Pertussis vaccine and encephalopathy after the Loveday trial.

Authors:  D W Scheifele
Journal:  CMAJ       Date:  1988-12-01       Impact factor: 8.262

2.  Incidence of pertussis in Canada.

Authors:  P Varughese
Journal:  Can Med Assoc J       Date:  1985-05-01       Impact factor: 8.262

3.  Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children.

Authors:  D W Scheifele; W Meekison; M Grace; L Barreto; A O Carter; L Mitchell; J Farley
Journal:  CMAJ       Date:  1991-09-15       Impact factor: 8.262

4.  Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors: 
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

5.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124
  5 in total
  1 in total

1.  Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Authors:  Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.